Most legitimate and solid company on the OTC. On track to significantly beat their 2016 revenue and script fill goals, and that's WITHOUT the robotic dispensing system in the equation. Now the robot is up and running and could easily double their monthly revenues for 2017. Great time to be in RXMD, and they are also working to fully audit.